Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.88 USD | +1.53% | +5.74% | +1.94% |
Apr. 23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
Apr. 23 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024 |
Financials (USD)
Sales 2024 * | 387M | Sales 2025 * | 525M | Capitalization | 1.27B |
---|---|---|---|---|---|
Net income 2024 * | -10M | Net income 2025 * | 38M | EV / Sales 2024 * | 2.65 x |
Net cash position 2024 * | 242M | Net cash position 2025 * | 386M | EV / Sales 2025 * | 1.68 x |
P/E ratio 2024 * |
-122
x | P/E ratio 2025 * |
32.7
x | Employees | 297 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.58% |
Latest transcript on Kiniksa Pharmaceuticals, Ltd.
1 day | +1.53% | ||
1 week | +5.74% | ||
Current month | -9.38% | ||
1 month | -10.47% | ||
3 months | -1.87% | ||
6 months | +18.02% | ||
Current year | +1.94% |
Managers | Title | Age | Since |
---|---|---|---|
Eben Tessari
FOU | Founder | 42 | 15-06-30 |
Sanj Patel
CEO | Chief Executive Officer | 54 | 15-06-30 |
Mark Ragosa
DFI | Director of Finance/CFO | 50 | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 15-09-30 |
Barry D. Quart
BRD | Director/Board Member | 67 | 15-09-30 |
Thomas Malley
BRD | Director/Board Member | 55 | 16-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 17.88 | +1.53% | 331,616 |
24-04-25 | 17.61 | -1.40% | 477,277 |
24-04-24 | 17.86 | +1.02% | 443,785 |
24-04-23 | 17.68 | +3.42% | 611,899 |
24-04-22 | 17.1 | +1.09% | 361,220 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.94% | 1.27B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- KNSA Stock